OVID Key Financial Ratios - Ovid Therapeutics Inc.

Complete source-backed ratio history.

Historical Key Financial Ratios

Date	Current ratio	Debt/equity	ROA	ROE
2026-06-30	12.39	—	-14.87%	-16.43%
2026-03-31	10.17	—	-10.71%	-12.19%
2025-12-31	8.97	—	-11.54%	-13.33%
2025-09-30	4.24	—	-56.90%	-81.28%
2025-06-30	4.72	—	-49.31%	-68.43%
2025-03-31	4.93	—	-30.58%	-42.13%
2024-12-31	5.32	—	-28.68%	-38.74%
2024-09-30	5.66	—	-31.66%	-42.60%
2024-06-30	5.73	—	-25.19%	-33.46%
2024-03-31	10.47	—	-38.50%	-64.74%
2023-12-31	9.55	—	-36.34%	-59.61%
2023-09-30	10.59	—	-38.81%	-47.90%
2023-06-30	10.07	—	-36.14%	-44.48%
2023-03-31	17.78	—	-35.86%	-42.51%
2022-12-31	18.79	—	-34.89%	-40.95%
2022-09-30	—	—	-41.61%	-48.34%
2022-06-30	—	—	-38.39%	-44.75%
2022-03-31	—	—	-36.25%	-41.99%
2021-12-31	12.87	—	63.14%	68.34%
2021-09-30	20.37	—	61.23%	64.36%
2021-06-30	19.12	—	55.86%	58.91%
2021-03-31	14.48	—	48.43%	52.01%
2020-12-31	3.39	—	-106.73%	-185.73%
2020-09-30	5.03	—	-82.94%	-119.38%
2020-06-30	3.02	—	-167.97%	-249.93%
2020-03-31	6.08	—	-108.05%	-129.64%
2019-12-31	7.58	—	-74.79%	-86.34%
2019-09-30	3.78	—	-138.58%	-187.68%
2019-06-30	5.84	—	-96.01%	-116.02%
2019-03-31	7.78	—	-78.91%	-91.88%
2018-12-31	5.01	—	-109.09%	-133.95%
2018-09-30	5.3	—	-82.86%	-100.14%
2018-06-30	8.7	—	-67.68%	-75.98%
2018-03-31	11.5	—	-55.61%	-60.69%
2017-12-31	14.71	—	-72.44%	-77.67%
2017-09-30	21.02	—	-62.94%	-66.06%
2017-06-30	15.19	—	-53.55%	-57.29%
2017-03-31	9.56	—	-112.22%	-125.12%
2016-12-31	14.04	—	-42.27%	-45.47%

Date	Current ratio	Debt/equity	ROA	ROE
2025-12-31	8.97	—	-11.54%	-13.33%
2024-12-31	5.32	—	-28.68%	-38.74%
2023-12-31	9.55	—	-36.34%	-59.61%
2022-12-31	18.79	—	-34.89%	-40.95%
2021-12-31	12.87	—	63.14%	68.34%
2020-12-31	3.39	—	-106.73%	-185.73%
2019-12-31	7.58	—	-74.79%	-86.34%
2018-12-31	5.01	—	-109.09%	-133.95%
2017-12-31	14.71	—	-72.44%	-77.67%
2016-12-31	14.04	—	-42.27%	-45.47%
2015-12-31	—	—	—	-19.33%